pressurised metered dose inhalers (pMDIs) [Regulatives / Guidelines]

posted by Mahesh M – India, 2014-09-12 10:46 (4310 d 06:49 ago) – Posting: # 13493
Views: 3,851

Dear All,
My concern is about Pharmacokinetic parameters for pressurised metered dose inhalers (pMDIs) EMA submission Study.

As per the guideline http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003504.pdf
London, 22 January 2009 Doc. Ref. CPMP/EWP/4151/00 Rev. 1 Section 6.1.1 (page no10.)

“In accordance with the standard accepted methods of assessment of bioequivalence the maximum concentration (Cmax), the area under the curve (AUC) and the time to Cmax (Tmax) should be compared.”

It means Bioequivalence depends on: Cmax. AUCt and Tmax?

Regards

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
213 visitors (0 registered, 213 guests [including 35 identified bots]).
Forum time: 17:36 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5